Combination of 177Lu ‐lilotomab with rituximab significantly improves the therapeutic outcome in pre‐clinical models of non‐Hodgkin's lymphoma

European Journal of Haematology,Volume 0, Issue ja, -Not available-.
Source: European Journal of Haematology - Category: Hematology Authors: Source Type: research
More News: Hematology | Lymphoma | Rituxan